This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: The Innovations of Serry Sousa
Introduction
Serry Sousa is an accomplished inventor based in North Wales, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibacterial compounds. His work has implications for medical research and treatment options.
Latest Patents
Serry Sousa holds a patent for "DNA encoding the SecA1 polypeptide of Staphylococcus aureus." This invention provides secA1 polypeptides and DNA (RNA) encoding secA1 polypeptides, along with methods for producing such polypeptides through recombinant techniques. Additionally, the patent outlines methods for utilizing secA1 polypeptides to screen for antibacterial compounds.
Career Highlights
Serry Sousa is associated with SmithKline Beecham Corporation, where he has been able to apply his expertise in biotechnology. His innovative work has contributed to advancements in the understanding and treatment of bacterial infections.
Collaborations
Throughout his career, Serry has collaborated with notable colleagues, including Karen M O'Dwyer and Caroline Perry. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Serry Sousa's contributions to biotechnology, particularly through his patent on the SecA1 polypeptide, highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in antibacterial research and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile